Inner Balance vs Alloy: Prices, FDA Status, and What We Verified About Both

The provider links in this article are editorial links. We earn no commission from Alloy or Inner Balance through the URLs shown here. See our affiliate disclosure.

Here’s the bottom line on Inner Balance vs Alloy: they are not two versions of the same service. Alloy is the stronger default for most women because it offers FDA-approved menopause medicines in multiple routes and costs less in year one. Inner Balance is the narrower fit for women who want one compounded estradiol-plus-progesterone vaginal cream and accept the trade-offs.

The key price: Inner Balance lists Oestra® at $199 a month for the first six months, then $99.50 a month. Alloy lists estradiol from $39.99 a month, progesterone from $23 a month, and a one-time $49 consultation fee.^[1][2]

That is the answer. Now here is the part that made us rebuild this page three times.

Both companies publish numbers about themselves. When we put those numbers side by side, some of Inner Balance's live figures did not match — including 98% and 49% for the same symptom category on different pages, and three different public descriptions of Oestra's dose. Both companies also publish outcome statistics without the study details a reader would need to evaluate them.

We will show you exactly where. But first, the decision you came for.

Which one is right for you?

Choose Alloy first if:

• You want a menopause medicine the FDA has reviewed and approved.
• You want to choose a route: pill, patch, gel, spray, or low-dose local vaginal cream.
• You have had a hysterectomy and may not need progesterone.
• You want the lower first-year cash price in every route we calculated.
• You value a public medical-team roster and named medical reviewers on product pages.
• You want the option to request that your prescription be transferred to another pharmacy.

Choose Inner Balance first if:

• An FDA-approved option cannot meet a documented medication or dosage-form need in your situation.
• You specifically want estradiol and progesterone in one vaginal application.
• You prefer monthly billing even though the medication ships in 90-day supplies.
• The advertised six-month refund window materially changes your willingness to try it — and you get the operative terms in writing before paying.
• You understand that Oestra is compounded and the finished product is not FDA-approved.

Neither one is your right first step if:

• You have new or unexplained vaginal bleeding after menopause.
• Your history calls for individual input before an asynchronous intake, including a history of a hormone-sensitive cancer, blood clot, stroke, heart attack, or serious liver disease.
• You want insurance to pay for the visit; neither company bills insurance.
• Your symptoms might not be menopause. Thyroid disease, anemia, sleep apnea, depression, medication effects, and other conditions can look similar.
• You need a physical examination, imaging, urgent evaluation, or emergency care.

Inner Balance vs Alloy at a glance

Decision point	Inner Balance — Oestra®	Alloy	Evidence status
What you get	One compounded vaginal cream containing estradiol and micronized progesterone	Separate FDA-approved menopause medicines: estradiol pill, patch, gel, spray, or low-dose vaginal cream; progesterone ordered separately when indicated	Provider pages checked Aug. 10, 2026[1][3]
FDA status of the medicine	Oestra is not FDA-approved	The menopause hormone medicines compared on this page are FDA-approved	Verified against provider pages and FDA compounding guidance[3][4]
Public price	$199/mo for 6 months, then $99.50/mo	Estradiol from $39.99/mo; progesterone from $23/mo; one-time $49 consult	Provider-stated prices checked Aug. 10, 2026[1][2][3]
First 90 days	$597.00	$237.97 for pill + progesterone to $342.97 for patch + progesterone	Calculated by The HRT Index from published base prices
First 12 months	$1,791.00	$804.88 for pill + progesterone to $1,224.88 for patch + progesterone	Calculated by The HRT Index
Ongoing annual base cost	$1,194.00	$755.88 for pill + progesterone to $1,175.88 for patch + progesterone	Calculated by The HRT Index
Consultation charge	No separate consultation fee listed	$49 one time; nonrefundable	Verified[2][5]
Public clinical roster	9 unique named people on the About page when checked: the founder, two other MDs, one NP, and five RNs; the page does not identify who will review your intake	22 public medical-team profiles when checked; 18 were labeled prescribing physicians	Counted on public team pages Aug. 10, 2026[6][33]
Refund headline	Up to six months of Oestra subscription fees, subject to policy terms	30 days from receipt for the first shipment of each eligible physical product	Verified in current policies[5][7]
HSA/FSA refund language	Two live pages conflict: the refund page says eligible; the HSA/FSA page says nonrefundable and excluded	HSA/FSA eligibility is advertised; product-refund terms do not state a payment-method exclusion	Verified Aug. 10, 2026[7][8]
Prescription transfer	Terms say you may choose another pharmacy, but Inner Balance may continue its monthly charge and you pay the pharmacy separately	Terms say you may request transfer to any pharmacy	Verified in both terms[5][9]
Insurance	Does not bill insurance; terms say not to submit a claim	Does not bill insurance; coverage after a pharmacy transfer depends on your plan and drug	Verified[5][9]
Independent Trustpilot pool	15 reviews; TrustScore 3.1/5; profile says the company has not invited reviews	3,855 reviews; TrustScore 4.3/5; company invites reviews and replies publicly	Snapshot checked Aug. 10, 2026[10][11]

What changes the answer for your situation?

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

→ Match my situation before I choose — Free. It does not diagnose or prescribe, and it flags when online care is not the right starting point.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

How we make money, plainly: the Alloy and Inner Balance URLs shown in this article are direct editorial links, not sponsored links. We earn no commission through them. If an affiliate relationship or destination changes later, the link label and sitewide disclosure must change with it.

What's the actual difference between Inner Balance and Alloy?

Inner Balance sells one core HRT product. Alloy sells a menu. Inner Balance's menopause offer centers on Oestra, a compounded vaginal cream containing estradiol and micronized progesterone. Alloy prescribes separate FDA-approved medicines and lets you choose the route — pill, patch, gel, spray, or a low-dose local vaginal cream — with progesterone as a separate prescription when it is indicated.^[1][3]

That structural difference explains almost every other difference between them.

One product means one price, one routine, one charge. It also means one route. Inner Balance publishes more than one Oestra strength, but it does not offer an internal switch to an FDA-approved pill, patch, gel, or spray if the compounded vaginal route does not suit you.

A menu means choice. It also means more decisions, more line items, and a first card charge that can be larger than the monthly number suggests because Alloy commonly ships and bills three months at a time.^[2]

Here is what each company publicly listed on August 10, 2026:

Inner Balance	Published price	Alloy	Published price
Oestra vaginal cream — estradiol + progesterone	$199/mo for 6 months, then $99.50/mo	Estradiol pill	From $39.99/mo
		Estradiol patch	From $74.99/mo
		Estradiol gel	$69.99/mo
		Evamist® estradiol spray	$69.99/mo
		Progesterone	From $23/mo
		Paroxetine, nonhormonal	$34.99/mo
		Low-dose estradiol vaginal cream	$119.97 per 3-month supply
		Low-dose birth-control pill	$39.99/mo

Alloy also sells products outside its menopause hormone line, including compounded products. Inner Balance also sells products outside Oestra. Those side catalogs are not the decision this page is resolving, but they matter for one reason: do not convert a company-level slogan into a product-level FDA claim. Check the exact medication you are being prescribed.

Is either one FDA-approved?

Alloy's menopause hormone medicines compared here are FDA-approved. Inner Balance's Oestra is not. Oestra is a compounded prescription product. The FDA has not reviewed that finished cream before marketing for safety, effectiveness, quality, dosing, or labeling.^[4]

This is the most important sentence on the page, so let us be precise.

Compounded does not mean fake or automatically inappropriate. Compounding has legitimate uses when a patient's medical need cannot be met by an available FDA-approved product. Oversight differs depending on whether a drug is prepared under the 503A patient-specific pharmacy pathway or by a 503B outsourcing facility. Neither pathway turns the finished drug into an FDA-approved product.^[4][12]

Where readers get tripped up: Inner Balance says the hormones in Oestra are also used in FDA-approved medicines. That does not make Oestra FDA-approved. The FDA approves specific finished products. FDA's June 2026 telehealth guidance specifically warns marketers not to describe a compounded drug as the same as an FDA-approved drug, a generic version of one, clinically proven to produce the same result, or sourced from an “FDA-approved” or “FDA-licensed” pharmacy.^[13]

Three claims you should read more carefully

1. “Bioidentical” is not a regulatory status. Both companies use the word. It describes a hormone's molecular structure; it does not tell you whether the finished product is FDA-approved, whether the dose has been evaluated, or whether one formulation is interchangeable with another. FDA-approved estradiol and micronized progesterone products can also be described as bioidentical.

2. Oestra does not list testosterone as an ingredient. Inner Balance's product page lists estradiol and micronized progesterone per pump. Other Inner Balance pages talk about testosterone “via conversion” from progesterone. That is a physiology claim, not a third ingredient in the bottle.^[3][14]

If you specifically want prescribed testosterone, Oestra is not that. Testosterone requires a separate prescription and is a Schedule III controlled substance in the United States.^[15] Neither company's standard menopause menu on this page includes a female testosterone product.

3. Alloy is not an “FDA-approved-only company.” Its menopause hormone line discussed here is FDA-approved, but Alloy also sells compounded products in other categories. The correct question is not “Is this company FDA-approved?” Companies are not approved that way. The question is: What exact finished medication am I being prescribed, and what is its regulatory status?

One more thing about the “FDA announcement” line

Inner Balance's live pages display the sentence “Estrogen is one of the most effective longevity interventions for women” and attribute it to an “FDA announcement, November 2025.”^[16]

A related statement appears in an FDA-hosted November 2025 podcast discussion, but the wording on Inner Balance's page is not an FDA-approved indication, prescribing-information statement, or agency conclusion about Oestra.^[17] The FDA's November 2025 action concerned labeling changes for FDA-approved menopausal hormone products. It did not make compounded products FDA-approved and did not create FDA-reviewed labeling for Oestra.

→ See Alloy's current FDA-approved menopause options and pricing — If FDA approval is your line in the sand, this is where that path starts. We earn nothing from this link.

Is Oestra systemic or local — and how is Alloy's vaginal cream different?

They are both applied vaginally, and they are not the same category of treatment. Inner Balance markets Oestra as a vaginal product intended for systemic, whole-body effects. Alloy's low-dose estradiol vaginal cream is positioned as a local treatment for genitourinary symptoms. Comparing them as though they were interchangeable “vaginal creams” can put you in the wrong treatment category.^[3][18]

This is genuinely easy to get wrong. Alloy's vaginal cream costs $119.97 per three-month supply — a medicine-equivalent price of $39.99 a month. Oestra starts at $199 a month. If you assume you are looking at the same treatment and pick only by price, you may buy a local product for symptoms that require a systemic discussion, or a systemic compounded product when your symptoms are local.

Question	Systemic treatment	Low-dose local vaginal treatment
Usually used for	Hot flashes, night sweats, and other body-wide menopausal symptoms	Vaginal dryness, burning, irritation, painful sex, and some urinary symptoms
Hormone exposure	Intended to create body-wide exposure	Primarily local tissue exposure; very little enters circulation with low-dose products
Inner Balance	Oestra is marketed in this category	Oestra is not marketed as a local-only product
Alloy	Estradiol pill, patch, gel, or spray	Low-dose estradiol vaginal cream
Progesterone question	If you have a uterus and use systemic estrogen, adequate endometrial protection matters	A progestogen is generally not required solely because of low-dose local vaginal estrogen

The Menopause Society distinguishes systemic therapy from low-dose vaginal estrogen and notes that very little low-dose vaginal estrogen reaches the circulation.^[18] “Vaginal” does not automatically mean “local.” Route, formulation, and dose all matter.

If your symptoms are only vaginal or urinary, Alloy's low-dose local cream is the closer FDA-approved comparison. Its published annual medicine cost is $479.88, or $528.88 if Alloy's $49 consultation fee applies to that product. That is about 27% to 30% of Oestra's first-year cost, not one-fifth.

If you also have hot flashes or night sweats, you are in a different conversation. A clinician may discuss systemic treatment, local treatment, or both.

The Oestra dose question you should ask before paying

Inner Balance currently publishes three Oestra dose descriptions across its product and help pages:^[3][19]

Where published	Estradiol	Progesterone	How the page describes it
Main Oestra product page	3 mg per pump	100 mg per pump	Generic product-page ingredient block
Help center — Oestra Start	About 2 mg	About 80 mg	Higher-dose, more intensive formula
Help center — Oestra Menopause	0.5 mg	50 mg	Lower-dose, gentler formula

Those numbers may represent different formulations rather than a dispensing error. The problem is simpler: the public product page does not clearly map its 3 mg/100 mg description to the two named formulas in the help center, so you cannot tell from the site which formula and strength you will receive.

We are not going to tell you those numbers are high or low. You cannot compare milligrams across different routes and formulations and reach a responsible conclusion in either direction. What you can ask is:

“Which Oestra formula and strength will I be prescribed, what amount does one pump deliver, and is there product-specific pharmacokinetic or endometrial-protection data for that exact formula?”

With an FDA-approved Alloy medicine, the strength and approved labeling can be looked up before you pay. With Oestra, the exact compounded prescription is determined through the clinical process.

Which costs more, Inner Balance or Alloy?

Alloy is cheaper in year one in every route we calculated. Inner Balance costs $1,791 in the first 12 months. Alloy's oral estradiol plus progesterone costs $804.88 including the $49 consultation, gel plus progesterone costs $1,164.88, and patch plus progesterone costs $1,224.88. In year two, the gap between Oestra and Alloy's patch route shrinks to $18.12.

Let us do this properly, because the headline prices create two different traps.

The Inner Balance price trap

Inner Balance's product page leads with “From $99.50/mo.”^[3]

That is the price after the first six months. You pay $199 a month for months one through six, then $99.50 a month.

Period	Billing pattern	Running total	Average monthly cost to that point
Months 1–3	$199/mo	$597.00	$199.00
Months 1–6	$199/mo	$1,194.00	$199.00
Months 1–12	6 months at $199, then 6 at $99.50	$1,791.00	$149.25
Months 1–24	Year one plus 12 months at $99.50	$2,985.00	$124.38

The honest comparison number for year one is $149.25 a month on average, not $99.50. Oestra does not average about $124 a month until you have paid for two full years.

Inner Balance also states that dose adjustments can cost extra and that optional labs may be ordered. It does not publish a universal lab price because the test and outside service can vary.^[9]

The Alloy price trap

Alloy's patch page displays “Starting at $74.99,” “1-month supply,” “Shipped and billed every 3 months,” and “3-month supply” on the same page.^[2]

The practical reading is that $74.99 is the monthly medicine price and the three-month medicine charge is approximately $224.97. With the one-time $49 consultation, the first patch-only charge is approximately $273.97. Add progesterone at Alloy's published $23 monthly starting price and the first 90-day total becomes $342.97.^[1][2]

That is not a hidden annual fee. It is a cash-flow issue: the monthly number is real, but the card charge can cover three months at once.

What each path actually costs

Calculated by The HRT Index from provider-published base prices checked August 10, 2026. The Alloy rows include one $49 consultation unless noted. They exclude taxes, promotions, dose changes, optional labs, extra medicines, and any price shown only after intake. Prescription decisions depend on the clinician.

Treatment path	Published monthly medicine basis	First 90 days	First 12 months	Ongoing annual base cost
Inner Balance — Oestra	$199 for 6 months, then $99.50	$597.00	$1,791.00	$1,194.00
Alloy — estradiol pill + progesterone	$39.99 + $23 = $62.99	$237.97	$804.88	$755.88
Alloy — estradiol gel + progesterone	$69.99 + $23 = $92.99	$327.97	$1,164.88	$1,115.88
Alloy — estradiol patch + progesterone	$74.99 + $23 = $97.99	$342.97	$1,224.88	$1,175.88
Alloy — estradiol pill only	$39.99	$168.97	$528.88	$479.88
Alloy — estradiol patch only	$74.99	$273.97	$948.88	$899.88
Alloy — low-dose vaginal estradiol cream only	$119.97 per 3 months	$119.97–$168.97*	$479.88–$528.88*	$479.88

\*Alloy's vaginal-cream page publishes the medicine price, but the page does not make clear whether the standard $49 consultation fee applies to that exact product. We show both outcomes instead of guessing. Confirm at checkout.

Five things this math tells you that neither headline does

1. Oestra costs $986.12 more than Alloy's pill-plus-progesterone route in year one. That is not a small premium. It is nearly a thousand dollars.
2. Against Alloy's patch-plus-progesterone route, Oestra costs $566.12 more in year one but only $18.12 more in the next full year. If the patch route is your actual alternative and you stay on treatment, the long-run price gap nearly disappears.
3. Alloy's lower annual total can come with a larger first charge. The patch-plus-progesterone path is approximately $342.97 for the first 90 days including the consultation. Inner Balance bills monthly even though it ships a 90-day supply.
4. After a hysterectomy, Alloy can become dramatically cheaper because a clinician may determine that estrogen alone is appropriate. The pill-only path is $528.88 in year one, versus $1,791 for Oestra, which includes progesterone.
5. If your symptoms are local vaginal or urinary symptoms only, the relevant Alloy medicine costs $479.88 a year before any applicable consultation fee, not $1,791. That is a different treatment category, not a bargain version of Oestra.

We used Alloy's published $23 monthly progesterone price in every combined calculation. We did not assume it was free, bundled, or discounted because Alloy's own live solutions page lists it as a separate product.^[1]

→ See Alloy's current per-product pricing — The company publishes its base medicine prices before intake. Confirm the card charge, dose, and consultation total before authorizing payment. Unpaid link.

Does a vaginal cream absorb better than a patch or a pill?

A vaginal route can bypass first-pass liver metabolism, but “better absorption” is not a universal multiplier and does not prove that one finished product works better than another. Inner Balance publishes several different numerical versions of its absorption advantage. None of the live pages we checked linked those figures to product-specific pharmacokinetic data for the Oestra formula a patient would receive.

Here is what Inner Balance currently says across its own pages:^[3][20][21]

Provider-owned page	Published claim	Implied comparison
Inner Balance vs Alloy	About 70% bioavailability versus 35% oral	About 2×
Other comparison/review pages	“4x higher bioavailability” than oral or topical routes	4×
Main Oestra product page	About 100% versus oral 10–20% or topical 3–20%	About 5–10× versus oral

Those are not small rounding differences. They describe materially different effects.

We are not going to adjudicate the pharmacology from marketing copy. The defensible conclusion is narrower:

• Vaginal delivery can produce systemic absorption when the formulation and dose are designed for it.
• Low-dose vaginal estrogen is a different category and produces limited systemic exposure.
• A product-specific absorption claim should be supported by data on that exact formulation, dose, and delivery system.
• We found no publicly linked Oestra-specific pharmacokinetic study on the pages reviewed as of August 10, 2026.

There is also no single blood estradiol target that decides whether standard menopausal hormone therapy is working for every woman. Clinical decisions usually depend on symptoms, history, route, dose, side effects, and the reason for treatment. The useful question is not “Which route has the biggest number?” It is: “What evidence supports the specific product and dose I am being prescribed?”

For Alloy's FDA-approved medicines, pharmacokinetic and labeling information is available in FDA-reviewed prescribing information. For Oestra, the public evidence is less product-specific. That is a real difference. It is not the same as saying the cream cannot work.

Who actually prescribes, and can you verify them?

Both companies now publish named clinical-team members, but Alloy's roster is larger and more explicit about which physicians prescribe. Inner Balance's About page names clinicians and nurses, but it does not state which person will review an individual intake. In both cases, get the assigned prescriber's name and verify the active license through your state board before relying on a credential headline.

Verification point	Alloy	Inner Balance
Public profiles counted Aug. 10, 2026	22 medical-team profiles	9 unique named people on the About page, including 3 MDs total, 1 NP, and 5 RNs
Profiles explicitly labeled “prescribing physician”	18	The About page describes the care team but does not label each person's prescribing role
Product-page medical reviewer	Named on major medicine pages	No separate named medical reviewer on the Oestra product page
Menopause/OB-GYN credentials	Many public profiles list FACOG and/or MSCP	One listed MD is shown as FACOG and MSCP; founder certification language appears elsewhere on the site
Can you verify the actual person assigned to you before treatment?	Ask for the assigned physician's name and check the state board	Ask for the assigned clinician's name and check the relevant state board

We removed the draft's exact count of MSCP and FACOG credentials because profile titles can change and some team members are advisors rather than prescribers. The durable difference is narrower: Alloy publishes the larger, role-labeled roster; Inner Balance publishes a smaller mixed clinician-and-nursing team page without identifying the person assigned to a specific intake.^[6][33]

What “board-certified” means in this comparison

Inner Balance describes its founder as board-certified and identifies the American Academy of Anti-Aging Medicine/American Board of Anti-Aging and Regenerative Medicine pathway in provider-owned comparison content.^[22]

That is a real private certification program. It is not one of the 24 Member Boards of the American Board of Medical Specialties. A4M's own materials describe formal subspecialty recognition as an objective the program seeks to achieve.^[23][24]

That distinction does not prove that a clinician is competent or incompetent. It means only this: “board-certified” is not enough information by itself. You deserve the name of the board.

Your 60-second verification either way

1. Ask for the full name and professional type of the person reviewing your intake and writing the prescription.
2. Look up that person on the medical, osteopathic, nursing, or physician-assistant licensing board for your state.
3. Confirm that the license is active and check any public disciplinary history.
4. If menopause certification matters to you, use The Menopause Society's practitioner directory.
5. Confirm the medication, strength, route, pharmacy, and refill cadence before the first charge.

→ Match your situation before you pay — Find My HRT Path helps you identify the provider model and questions your situation calls for, including when online care is not the right first step.

Can you get your money back at either one?

Inner Balance advertises the longer window: up to six months of Oestra subscription fees. Alloy's window is 30 days and applies only to the first shipment of each eligible physical product. The damaging detail is that Inner Balance's two live pages directly conflict on whether an HSA/FSA purchase qualifies for the guarantee.^[5][7][8]

This is the section where Inner Balance's headline looks better, and it does. Six months is longer than 30 days. The fine print still decides whether the promise applies to your payment.

Refund or cancellation term	Alloy	Inner Balance
Advertised refund window	30 days from receiving the eligible shipment	Within 6 months of original Oestra order
Which purchases qualify	First shipment of each eligible physical product	Up to 6 months of Oestra subscription fees; one refund per customer
Consultation or service fees	$49 consultation and service/subscription charges are nonrefundable	No separate consultation fee listed
How to request	Email support with order information and reason	Message the Care Team through secure account chat
Automatic when you cancel?	No	No
Additional deadline	First-shipment request within 30 days of receipt	Request within 14 days of cancellation and within 6 months of original order
HSA/FSA treatment	No specific payment-method exclusion in the refund section	Conflict: refund page says eligible; HSA/FSA page says nonrefundable and excluded
Cancel subscription	At least 7 days before current subscription period ends	Terms say you may cancel through the portal at any time
Pause/cancel next shipment	At least 5 business days before processing	If you received 3 months and cancel before all 3 monthly payments are collected, a reactivation fee may apply
Physical return	Products cannot be returned once dispensed	Policy describes refunds, not a return requirement

Three things buried in those policies that can cost you

1. A refund and a return are not the same thing at Alloy. Alloy says eligible first-shipment product charges can be refunded within 30 days, while the physical product itself cannot be returned. The consultation and service charges are not refundable.^[5]

2. Inner Balance has two incompatible HSA/FSA answers live at once. Its refund policy says HSA/FSA purchases are eligible. Its HSA/FSA page says they are nonrefundable and not valid under the six-month guarantee.^[7][8]

If the guarantee is what makes you comfortable trying Oestra, do not rely on either webpage alone. Before paying, send this exact message through support and save the response:

“I plan to pay with [credit card/HSA/FSA]. If I cancel and request an Oestra refund within six months of my original order and within 14 days of cancellation, will this payment method qualify? Please send the terms that will control my order.”

3. Cancelling is not refunding. At both companies, cancelling stops a future renewal only if you meet the cancellation deadline. A refund requires a separate request and separate eligibility.

The three dates to save before you pay

Write these in your calendar and screenshot the policy pages on the purchase date:

• Order/receipt date — starts the refund window.
• Subscription cancellation deadline — stops the next membership period.
• Shipment processing deadline — stops the next pharmacy shipment where the policy allows it.

A dated screenshot is not paranoia. It is the fastest way to preserve the exact promise you relied on if a policy page changes later.

Can you use insurance, an HSA, or an FSA?

Neither company bills insurance for the online service. The difference is what can happen to the prescription afterward. Alloy's terms allow you to request a transfer to another pharmacy, so coverage depends on the exact FDA-approved drug, your pharmacy benefit, formulary, deductible, and prior-authorization rules. Inner Balance's bundled Oestra service is cash-pay, and its terms say you agree not to submit a claim.^[5][9]

The visit and the medicine are separate questions only when the prescription can be filled outside the provider's bundled program.

Payment and pharmacy question	Alloy	Inner Balance
Bills insurance for the online service?	No	No
HSA/FSA advertised?	Yes on product pages	Yes for Oestra
Itemized documentation	Request documentation from Alloy as needed	Inner Balance offers a Letter of Medical Necessity when an account requires it
Named dispensing pharmacies	Curexa Pharmacy (NJ), BLEND Pharmacy (OH), and Gogo Pharmacy (KY) are named in the terms	Oestra's filling pharmacy is not publicly named on the pages reviewed
Request transfer to another pharmacy?	Yes, under the terms	Yes, but Inner Balance may continue charging its monthly service fee and you pay the outside pharmacy separately
Insurance claim clause	Service is not insurance; no direct billing	Terms say the patient will not submit claims and agrees to indemnify Inner Balance for claims arising from submission
HSA/FSA refund treatment	Product-refund section does not state a payment-method exclusion	Current pages conflict; get the answer in writing

The 503A versus 503B question is unresolved on Inner Balance's own site

Inner Balance's live treatment pages display a 503A pharmacy badge or statement. Other Inner Balance-owned pages describe its partner as a 503B facility.^[16][25]

Those are not interchangeable labels:

• 503A generally refers to patient-specific compounding by a state-licensed pharmacy or physician under section 503A.
• 503B refers to an outsourcing facility registered with the FDA and subject to additional federal requirements, including current good manufacturing practice requirements and risk-based FDA inspection.
• Neither means the finished compounded medication is FDA-approved.

FDA also says it does not “approve” or “license” pharmacies or outsourcing facilities, so a phrase like “FDA-approved pharmacy” would be inaccurate.^[13]

Before paying for Oestra, ask:

“Which legal entity and physical pharmacy will compound my prescription, is it operating under 503A or 503B for my order, and where can I verify its current state license or FDA registration?”

HSA and FSA records still matter

Inner Balance's HSA/FSA page says no receipts are needed when its card processes the transaction. Keep the receipt anyway. An HSA owner is responsible for maintaining records that show a distribution was used for a qualified medical expense, and an FSA administrator may require substantiation or additional documentation.^[26]

The safe rule is simple: card acceptance does not settle tax eligibility, plan eligibility, or refund eligibility. Save the receipt, prescription documentation, Letter of Medical Necessity if issued, and the written answer about the refund policy.

→ Compare online HRT provider models — Use this if you need an insurance-billing provider, video visits, local pharmacy access, or a model neither Inner Balance nor Alloy offers.

What changes if you still have a uterus?

If you use systemic estrogen and still have a uterus, adequate endometrial protection matters. Alloy can prescribe a separate FDA-approved progesterone product when indicated. Inner Balance includes compounded progesterone in Oestra. The unresolved question is not whether progesterone is present; it is whether the exact compounded formula, dose, and regimen provide adequate protection for the endometrium.^[27]

If you have an intact uterus

The British Menopause Society's current progestogen guidance states that women with a uterus using systemic estrogen need a progestogen regimen that adequately opposes the estrogen effect. It also says evidence is lacking that progesterone doses in compounded preparations provide sufficient endometrial protection and does not recommend compounded progesterone products for that purpose.^[28]

Inner Balance's position is different. Its pages cite vaginal absorption and a “first uterine pass” concept and state that Oestra's progesterone protects the uterine lining.^[16]

Both points do not become product-specific evidence automatically. Research on vaginal progesterone as a route does not prove that one compounded Oestra formula at one dose provides adequate protection alongside its estradiol dose.

The ELITE trial is relevant because it shows why the question is real. In that regimen, 45 mg of vaginal progesterone gel for 10 days each month did not completely oppose the endometrial effects of 1 mg oral estradiol over the study period.^[28] That result cannot be used to declare Oestra adequate or inadequate; it shows that route and milligrams alone do not settle the issue.

We will not compare the milligram numbers and pretend we can answer it. Ask the prescriber:

“I have a uterus. If this compounded cream is my only systemic hormone therapy, what evidence supports the progesterone regimen for protecting my uterine lining, and what monitoring or bleeding plan will you use?”

Blood testing is not the same as monitoring the uterine lining. A hormone level does not substitute for evaluation of postmenopausal bleeding or endometrial pathology. Imaging and tissue sampling answer different questions.

If you have had a hysterectomy

You may not need progesterone. That is where Alloy's modular model can save real money: the published estradiol-only paths in our ledger cost $528.88 to $948.88 in year one, versus $1,791 for Oestra.

The general rule has exceptions. A clinician may consider a progestogen in some situations involving residual endometrium, certain procedures, or significant residual endometriosis. If you are not certain whether you had a total or supracervical hysterectomy, check your operative record rather than guessing from memory.

If you have a hormonal IUD

A 52 mg levonorgestrel-releasing intrauterine system may provide endometrial protection in an HRT regimen under clinician guidance, but the device type, age, indication, and replacement date matter.^[28] Do not assume every hormonal IUD covers this role and do not add progesterone on your own.

If you have new bleeding after menopause

Stop comparing checkout pages and contact a clinician. Bleeding 12 months or more after the final menstrual period should be evaluated. ACOG's 2026 update recommends that the initial evaluation for most patients include both transvaginal ultrasonography and endometrial tissue sampling, with limited exceptions for carefully selected cases.^[29]

A portal message can start that process. It cannot perform the ultrasound or tissue sampling.

Do the outcome numbers hold up?

Both companies publish improvement statistics without enough public methodology to treat them as clinical evidence. Alloy currently publishes one prominent 95% figure on its patch page. Inner Balance publishes materially different outcome percentages across its own live pages, including 98% and 49% for vaginal dryness.^{[2][3][16][20][21]}

This finding changed how we wrote the rest of this comparison.

Provider-owned page	How the number is framed	Vaginal dryness	Sleep	Mood/mental health	Focus/brain fog
Main Oestra product page	“6-month outcomes review”	98%	81%	80%	85%
Main Inner Balance HRT treatment page	“8-week outcome review”	98%	81%	80%	85%
Inner Balance Winona review	“8-week internal outcome review”	49%	41%	40%	43%
Inner Balance vs Alloy page	“Internal data from six-month users”	97%	80.2%	78.7%	67.6%

Read the first and third rows again: 98% and 49% for the same symptom category on different live pages. The same 98% result is also labeled as both a six-month and an eight-week review on two separate pages. The framing is not stable enough to treat any of these numbers as a settled clinical result.

The pages reviewed do not provide the sample size, participant selection, attrition, survey questions, missing-data handling, comparison group, protocol, or a peer-reviewed publication for these figures. That means a reader cannot tell whether the percentages describe all enrolled users, survey respondents, treatment completers, or another group.

In fairness to Inner Balance: internal customer outcome data is not automatically fabricated. Telehealth companies routinely publish internal figures. Alloy does too: its patch page says 95% of customers taking HRT feel symptom relief in two weeks or less, without a linked study methodology on the page.^[2]

Neither company's percentage should decide which medicine you take. The useful distinction is that Inner Balance's figures conflict across its own pages, while Alloy's prominent figure remains a provider-reported marketing statistic rather than an independently evaluated clinical result.

What to do with this: when a percentage is part of the reason you are paying, look for five things before treating it as evidence — sample size, time point, question wording, denominator, and study method. If they are absent, treat the percentage as provider-reported marketing data.

What is each one actually like day to day?

Inner Balance is simpler on paper: one compounded vaginal cream, applied daily, with one monthly charge. Alloy may mean two prescriptions — estrogen plus progesterone — but the estrogen route is yours to choose. If you do not need progesterone, Alloy can be a single pill, patch, gel, spray, or local vaginal product.

The friction you will actually feel	Inner Balance	Alloy
Number of medicines	One Oestra product	One or two hormone medicines depending on the plan
Vaginal application	Required for Oestra	Optional; required only if you choose the vaginal cream
Patch adhesive	None	Possible if you choose the patch
Pill to swallow	None in the base Oestra regimen	Estradiol pill if chosen; oral progesterone may be part of a combined plan
Gel or spray drying/transfer precautions	Not applicable	Relevant if you choose gel or spray; follow the label
Switching route within the company	Limited to the vaginal compounded model and its formulas	Stronger route flexibility across pill, patch, gel, spray, and local cream
Shipment and billing	90-day supply; billed monthly	Product-dependent; major HRT pages commonly state three-month shipment/billing
Clinician messaging	Provider-stated ongoing access included	Unlimited doctor messaging while the prescription is active after the one-time consult
Treatment-plan timing	Provider says review generally occurs in 24–48 hours	Provider says a plan may be delivered in less than 12 hours
Labs to start	Not routinely required; optional tests may be ordered	Not routinely required for standard intake; clinician may request information or testing
Video visit	Not routinely required	Asynchronous intake is available; clinician determines what is needed

“No labs required” is not automatically a strength or a weakness. Menopause care is often based on symptoms, menstrual history, age, and risk history, and routine hormone levels are not always necessary. But testing can matter when symptoms could come from thyroid disease, anemia, metabolic disease, pregnancy, medication effects, or another condition.

The absence of routine labs tells you less than the quality of the clinical review. The question is whether someone competent recognized when not to treat the intake as straightforward menopause.

What do real customers say about each?

Reviews are most useful for identifying operational patterns — billing, shipping, cancellation, portal communication, and refund handling — not for determining whether a hormone treatment is safe or effective. The two independent review pools are too different in size and collection history to average as though they were equivalent.^[10][11]

Review snapshot on Aug. 10, 2026	Alloy	Inner Balance
Trustpilot reviews	3,855	15
Trustpilot score	4.3/5	3.1/5
Company invites reviews?	Yes	Trustpilot says no history of asking for reviews
Replies to negative reviews	Trustpilot shows a high public response rate	Profile is unclaimed and has a very small review pool
Reviews displayed on provider site	Yes	4.9/5 and 5,695 reviews displayed on product pages; another page says trusted by 60,000+ women

A company's on-site review system and an independent platform answer different questions. A provider controls where and how its own testimonials are selected and displayed. Trustpilot controls its own moderation process, though it is still a review platform rather than a clinical study.

The operational complaint themes visible in the independent pools include subscription expectations, cancellation, refund decisions, shipping, support response, and payment sequence. Those are allegations from individual reviewers, not established facts about every customer.

The provider terms are the better source for what can be verified:

• Alloy auto-renews, has a seven-day subscription-cancellation deadline, a five-business-day shipment deadline, and a limited first-shipment refund policy.^[5]
• Inner Balance takes payment as part of enrollment, allows clinician rejection and return of subscription fees, bills 90-day Oestra shipments monthly, and requires a separate refund request through secure chat.^[7][9]

You pay before you know every clinical detail. That is normal in many direct-to-consumer telehealth models, but it means you should know the refund, denial, and timing rules before entering your card.

We did not include customer efficacy testimonials in this comparison. A personal story can explain an experience. It cannot prove that a treatment is effective or safe for another person.

When is Inner Balance genuinely the better answer?

Inner Balance becomes the more defensible choice when the vaginal combined dosage form itself solves a documented need that available FDA-approved products do not. That is a narrower case than “I prefer something natural,” but it is real.

FDA-approved oral products that combine estradiol and progesterone exist, including Bijuva® and an approved generic estradiol/progesterone capsule.^[30] We did not identify an FDA-approved product that combines estradiol and progesterone in a vaginal cream. Alloy does not offer that one-bottle vaginal combination.

The National Academies' FDA-commissioned review recommended restricting compounded bioidentical hormone therapy to situations such as a documented allergy to an ingredient in an FDA-approved product or a documented requirement for a dosage form that is not available FDA-approved. It explicitly said patient preference alone should not determine use.^[31]

ACOG reaches the same practical starting point: compounded menopausal hormone therapy should not be prescribed routinely when an FDA-approved formulation can meet the patient's needs, and clinicians should explain the lack of FDA approval and the limits of the evidence.^[32]

That gives Inner Balance a legitimate lane:

• You need a vaginal combined estradiol-plus-progesterone dosage form rather than merely liking the idea of one.
• An allergy or excipient problem rules out an available approved product.
• You and the prescriber have a documented reason an approved pill, patch, gel, spray, or separate local treatment does not meet the need.
• You understand that the finished Oestra product is compounded and that public product-specific evidence remains limited.

Preference still matters. It just should not do the work of evidence. One application, one bottle, monthly billing, and a vaginal route may make adherence easier for you. The responsible question is whether those conveniences sit on top of a defensible clinical rationale.

If you have already tried an FDA-approved route, say exactly what happened in the intake: the product, dose if known, how long you used it, what problem remained, and what made you stop. That is more useful than writing “HRT did not work.”

→ Check whether Oestra fits your situation (editorial link — no commission through this URL) — A prescription is required and a licensed clinician decides eligibility. Before paying, ask which formula and strength you would receive, what protects the uterine lining if you have a uterus, which pharmacy pathway applies, and which refund terms control.

What's the trade-off nobody tells you about the FDA-approved route?

Alloy does not give you one product that does what Oestra is designed to do. If you have a uterus and need systemic estrogen, Alloy may mean managing two prescriptions instead of one: an estrogen product and progesterone. That means two line items, potentially two routines, and more decisions.

No amount of marketing changes that inconvenience. The FDA-approved oral estradiol/progesterone combinations are capsules, not vaginal creams. Alloy's local vaginal estrogen does not replace systemic treatment for hot flashes or night sweats. If one vaginal application is the dosage form you genuinely need, Inner Balance offers something Alloy does not.

If a one-bottle, one-charge, one-step routine is what you are buying — and the compounded route has a documented reason in your case — Inner Balance is simpler. We would rather lose your Alloy click than pretend otherwise.

But here is what the separate FDA-approved route can buy you:

1. A finished medicine reviewed by the FDA before marketing.
2. Approved prescribing information with the dose, indications, warnings, and administration instructions in one place.
3. A choice among pill, patch, gel, spray, and low-dose local vaginal treatment.
4. A public medical-team roster and named medical reviewers on major product pages.
5. A stated right to request prescription transfer to another pharmacy.
6. A chance that an FDA-approved prescription may be covered through your pharmacy benefit after transfer, depending on the drug and plan.
7. Between $566.12 and $986.12 less in year-one base cost for the combined systemic routes we calculated.

Two prescriptions can be the price of all seven.

That is the trade. Not “one is good and one is bad.” One is simpler and compounded. The other is more modular, more publicly verifiable, and FDA-approved at the product level. You get to decide which difference actually resolves your problem.

→ Work through the six questions that decide this — Find My HRT Path covers symptom type, uterus status, route preference, risk history, insurance, and state — and flags when online care is not the right starting point.

When is neither Inner Balance nor Alloy the right starting point?

Asynchronous online hormone care is not the right first move for every woman. Some symptoms need an examination, imaging, laboratory work, urgent care, or input from a clinician who already knows your oncology or cardiovascular history.

Arrange an in-person or established-clinician evaluation first if you have:

• New or unexplained bleeding after menopause.
• A personal history of breast, uterine, ovarian, or another hormone-sensitive cancer.
• A history of blood clots, stroke, heart attack, or serious cardiovascular disease.
• Significant liver disease.
• A possible pregnancy.
• A breast lump, pelvic mass, severe pelvic pain, or another symptom that needs a physical examination.
• Symptoms changing quickly enough that waiting for asynchronous messages does not feel safe.
• Chest pain, sudden weakness, trouble speaking, severe shortness of breath, or another emergency symptom — use emergency care, not a telehealth comparison page.

Consider a different provider model if:

• You need insurance to cover the visit. Neither Inner Balance nor Alloy bills insurance for the menopause-care service.
• You want the same clinician following you over time by scheduled video or in person. Both models are built around asynchronous care.
• Your symptoms may have another cause. Fatigue, brain fog, sleep disruption, low mood, palpitations, and hair changes can also occur with thyroid disease, anemia, sleep apnea, medication effects, pregnancy, mood disorders, and other conditions.
• You need diagnostic testing before a treatment decision. Convenience is not a substitute for the missing test.

If any of that describes you, the correct next step is not a checkout page. It is the evaluation that removes the uncertainty first.

How did The HRT Index compare Inner Balance and Alloy?

We read the live product pages, prices, policies, terms, clinical-team pages, and provider claims; calculated comparable 90-day, first-year, and ongoing costs; and checked medical and regulatory statements against primary sources. We did not convert company marketing into clinical evidence.

This is The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly. We evaluate providers on five pillars, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not publish numeric provider scores or invented star ratings.

What we actually verified on August 10, 2026

• Alloy's published menopause-product prices and $49 consultation charge.
• Alloy's current terms, including automatic renewal, cancellation deadlines, refund limits, named dispensing pharmacies, and prescription-transfer language.
• Alloy's public medical-team roster and the labels used on those profiles.
• Inner Balance's current named care-team page and the credentials displayed there.
• Inner Balance's Oestra price schedule, 90-day shipping model, terms, refund page, and HSA/FSA page.
• The live conflict between Inner Balance's two HSA/FSA refund statements.
• Three public Oestra dose descriptions.
• Inner Balance's conflicting 503A and 503B descriptions across provider-owned pages.
• The FDA status of compounded drugs and FDA's current rules for telehealth promotion of compounded products.
• The public outcome-claim drift and absorption-claim drift described above.
• Trustpilot review counts, scores, claimed status, and review-invitation labels as a dated platform snapshot.

What remains provider-stated rather than independently tested by us

• How quickly either company actually returns a treatment plan for a typical patient.
• Whether unlimited messaging feels responsive in practice.
• The specific Oestra formula an individual patient receives.
• Any provider-reported symptom-improvement percentage.
• The on-site review counts and ratings displayed by either company.
• Whether a six-month Inner Balance refund request is approved in a particular case.

What we could not verify from public information

• A complete, current state-by-state availability list for either company. Inner Balance's own pages publish inconsistent totals; Alloy does not publish one complete list.
• The identity of the pharmacy that would dispense a specific Oestra order.
• Whether that specific order would be filled under a 503A or 503B pathway.
• Whether Alloy's $49 consultation fee applies to its low-dose vaginal cream in every checkout path.
• Public product-specific pharmacokinetic or endometrial-safety data for each Oestra formula.
• The name of the independent Inner Balance clinician who would review a particular intake before payment.
• Insurance coverage for an Alloy prescription after transfer; that is plan- and drug-specific.

What we did not do

We did not complete a paid intake, receive medication, inspect a shipment, submit an insurance claim, execute a cancellation, request a refund, or time clinician responses. Where a fact can be confirmed only through intake, checkout, a pharmacy, or an individual plan, this page says so instead of guessing.

What could change after publication

Element	Refresh cadence	Verification method
Public prices, consult charges, shipping cadence	Monthly	Recheck product pages and checkout disclosures
Refund, cancellation, renewal, arbitration, and transfer terms	Monthly	Re-read current terms and refund policies; archive dated copies
HSA/FSA and insurance language	Monthly	Compare all provider policy pages and terms
Product formulation and dose descriptions	Monthly	Recheck product and help-center pages
FDA or compounding status	Quarterly and on regulatory news	FDA Drugs@FDA, compounding guidance, and provider product pages
Clinician roster and credentials	Quarterly	Provider roster, state boards, and relevant professional directories
State availability	Monthly	Provider eligibility flow or written support confirmation
Trustpilot snapshots	Quarterly	Record count, score, claimed status, and invitation label with date
Medical guidance cited here	Quarterly	FDA, ACOG, The Menopause Society, BMS, and peer-reviewed sources

Found something we got wrong? Tell us. We will verify it, correct it, and date the change. That is the deal.

Frequently asked questions

Is Inner Balance better than Alloy?

For most women comparing the two, Alloy is the stronger default because the menopause medicines discussed here are FDA-approved, the route options are broader, the public clinical roster is more visible, and the first-year base cost is lower. Inner Balance is the narrower fit when a combined vaginal estradiol-plus-progesterone dosage form meets a documented need that available approved options do not.

Is Oestra FDA-approved?

No. Oestra is a compounded prescription product. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing, and the finished Oestra product is not FDA-approved.^[4]

Are Alloy's hormone medicines FDA-approved?

The estradiol pill, patch, gel, spray, low-dose vaginal cream, and progesterone products compared on this page are presented by Alloy as FDA-approved medicines. Alloy also sells compounded products in other categories, so confirm the regulatory status of the exact medication on your treatment plan.

Does Oestra contain testosterone?

No testosterone is listed in Oestra's published ingredient block. Inner Balance lists estradiol and micronized progesterone and separately discusses possible testosterone conversion from progesterone. That does not put testosterone in the bottle.^[3][14]

Is testosterone a controlled substance?

Yes. Testosterone is a Schedule III controlled substance in the United States and requires a prescription.^[15] Oestra is not a testosterone prescription.

Which costs less in the first year?

Alloy costs less in every route calculated here. The first-year base total is $804.88 for pill plus progesterone, $1,164.88 for gel plus progesterone, and $1,224.88 for patch plus progesterone, compared with $1,791 for Oestra.

Which costs less after the first year?

It depends on the Alloy route. Oestra's ongoing published base cost is $1,194 a year. Alloy's pill-plus-progesterone route is $755.88, gel plus progesterone is $1,115.88, and patch plus progesterone is $1,175.88. The ongoing difference between Oestra and the patch route is $18.12 a year at the prices checked.

Is Oestra the same as Alloy's vaginal estrogen cream?

No. Oestra is a compounded estradiol-plus-progesterone cream marketed for systemic effects. Alloy's low-dose FDA-approved vaginal estradiol cream is a local treatment for vaginal and urinary symptoms. They are not interchangeable categories.

Do I need progesterone with Alloy?

If you have a uterus and use systemic estrogen, adequate endometrial protection generally requires a progestogen. After a hysterectomy, progesterone may not be needed, though exceptions exist. Low-dose local vaginal estrogen is a different situation and generally does not require a progestogen solely for endometrial protection. Your clinician makes the decision.^[27][28]

Is Oestra's progesterone proven to protect the uterine lining?

We did not find public product-specific endometrial-safety evidence for each Oestra formula. Current BMS guidance says evidence is lacking that progesterone doses in compounded preparations provide sufficient protection and calls for caution with vaginal progesterone regimens.^[28] Ask what protects your lining and how it will be monitored.

Do Inner Balance or Alloy take insurance?

Neither company bills insurance for the menopause-care service. Alloy's terms allow a prescription-transfer request, so an FDA-approved drug may be eligible for pharmacy-benefit coverage after transfer depending on your plan. Inner Balance's terms say not to submit an insurance claim for its service.^[5][9]

Can I use an HSA or FSA?

Both companies advertise HSA/FSA eligibility. Inner Balance's live pages conflict about whether an HSA/FSA-funded purchase qualifies for its six-month refund guarantee. Get that answer in writing before paying with an account card and retain the prescription, invoice, and plan documentation.^[7][8]

Can I cancel either service at any time?

Both let you request cancellation, but deadlines control what happens next. Alloy requires subscription cancellation at least seven days before the period ends and shipment changes at least five business days before processing. Inner Balance permits portal cancellation, but a three-payment cycle and possible reactivation fee appear in its terms, and refunding is a separate request.^[5][7][9]

Does either require laboratory tests or a video appointment?

Neither publicly requires routine hormone testing or a video appointment for every standard intake. A clinician may still request records, testing, video, or in-person evaluation based on symptoms and history. “No routine labs” does not mean testing is never appropriate.

Which is better after a hysterectomy?

Alloy is usually the more flexible and lower-cost model because estrogen-only treatment may be appropriate and Oestra includes progesterone. At the checked prices, Alloy's pill-only first year is $528.88, which is $1,262.12 less than Oestra. Your clinician must confirm whether estrogen-only treatment fits your surgical and medical history.

Which is better for vaginal dryness or painful sex only?

Alloy's low-dose local vaginal estradiol cream is the closer FDA-approved comparison when symptoms are limited to vaginal or urinary tissues. Its published annual medicine price is $479.88, or $528.88 if the $49 consultation applies. Hot flashes or night sweats change the treatment category.

Can I switch from one to the other?

Only with clinician guidance. Give the new prescriber the exact product, formula, dose, frequency, start date, and last dose. Do not stop, start, or overlap systemic hormone treatment based on a comparison page.

Is either appropriate after breast cancer?

That decision needs individual input from the clinicians managing your oncology history. Do not begin systemic hormone therapy through an online intake based on this comparison. For genitourinary symptoms, discuss the options with your oncology and menopause-care teams.

The bottom line

The better choice is not the one with the louder promise. It is the model that fits your symptoms, uterus status, route needs, budget, risk history, and need for verifiable information.

Alloy is the stronger default for most women: FDA-approved menopause medicines in multiple routes, a public medical-team roster, prescription-transfer language, and $804.88 to $1,224.88 in first-year base cost for the combined systemic routes calculated here instead of $1,791.

Inner Balance is the better fit for a narrower situation: you have a documented reason an FDA-approved route or dosage form does not meet your need, you specifically want one compounded vaginal estradiol-plus-progesterone application, and the convenience is worth the regulatory, evidence, and policy trade-offs. Ask which formula you will receive, what protects your uterine lining, which pharmacy pathway applies, and which refund terms control before you pay.

Neither is the right first step when you need insurance to cover the visit, have new bleeding after menopause, need a physical examination or imaging, have a high-risk history requiring established-clinician input, or may be dealing with something other than menopause.

Whichever way you lean, verify four things before entering your card: the exact medicine and dose, the full first charge, your state eligibility, and the cancellation/refund deadlines. All four are easier to confirm before payment than to untangle afterward.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

→ Use Find My HRT Path

More from The HRT Index:

• Compare the best online HRT providers
• See real online HRT costs for 2026
• Read the vaginal estrogen guide
• Review HRT benefits, risks, and fit

---

This page is educational editorial research, not medical advice, and has not been reviewed by a clinician. Hormone-treatment decisions should be made with a licensed clinician who can review your history. Prices, policies, review counts, and provider statements were verified on August 10, 2026 and can change. Confirm the exact medication, total charge, state availability, and operative terms during intake or checkout.

Affiliate disclosure: the provider URLs shown on this page are direct editorial links. The HRT Index earns no commission from Alloy or Inner Balance through these links. If a provider relationship or destination changes, the link must be relabeled and the sitewide disclosure updated before publication.

Sources

The numbered sources below support claims cited throughout this article. Select a source number in the text to jump here.

1. 1. Alloy, https://www.myalloy.com/solutions" target="_blank" rel="noopener">Solutions and current product pricing, checked August 10, 2026. ↩
2. 2. Alloy, https://www.myalloy.com/solutions/estradiol-patch" target="_blank" rel="noopener">Estradiol patch product page, including the monthly display price, three-month shipping/billing language, consultation charge, and provider-reported outcome claim; checked August 10, 2026. ↩
3. 3. Inner Balance, https://www.innerbalance.com/product-page" target="_blank" rel="noopener">Oestra product page, including the price schedule, shipping cadence, ingredient block, dose description, and provider absorption claim; checked August 10, 2026. ↩
4. 4. U.S. Food and Drug Administration, https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers" target="_blank" rel="noopener">Compounding and the FDA: Questions and Answers, accessed August 10, 2026. ↩
5. 5. Alloy, https://www.myalloy.com/terms-of-use" target="_blank" rel="noopener">Terms of Use, revised May 28, 2026; accessed August 10, 2026. ↩
6. 6. Alloy, https://www.myalloy.com/who-we-are" target="_blank" rel="noopener">Medical Team, counted and checked August 10, 2026. ↩
7. 7. Inner Balance, https://www.innerbalance.com/p/refund-policy" target="_blank" rel="noopener">Refund Policy, accessed August 10, 2026. ↩
8. 8. Inner Balance, https://www.innerbalance.com/p/hsa-fsa/" target="_blank" rel="noopener">HSA/FSA eligibility and refund language, accessed August 10, 2026. ↩
9. 9. Inner Balance, https://www.innerbalance.com/p/terms-of-use" target="_blank" rel="noopener">Terms & Conditions and Terms of Use, accessed August 10, 2026. ↩
10. 10. Trustpilot, https://www.trustpilot.com/review/www.innerbalance.com" target="_blank" rel="noopener">Inner Balance profile, 15 reviews and TrustScore 3.1/5; snapshot checked August 10, 2026. ↩
11. 11. Trustpilot, https://www.trustpilot.com/review/myalloy.com" target="_blank" rel="noopener">Alloy profile, 3,855 reviews and TrustScore 4.3/5; snapshot checked August 10, 2026. ↩
12. 12. U.S. Food and Drug Administration, https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding" target="_blank" rel="noopener">Human Drug Compounding, accessed August 10, 2026. ↩
13. 13. U.S. Food and Drug Administration, https://www.fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs" target="_blank" rel="noopener">FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs, accessed August 10, 2026. ↩
14. 14. Inner Balance, https://help.innerbalance.com/en/articles/12760352-oestra-for-everyone" target="_blank" rel="noopener">Oestra comparison and help-center content discussing “testosterone conversion”, checked August 10, 2026. ↩
15. 15. U.S. Drug Enforcement Administration, https://www.dea.gov/drug-information/drug-scheduling" target="_blank" rel="noopener">Controlled Substances Act scheduling information for anabolic steroids and testosterone, accessed August 10, 2026. ↩
16. 16. Inner Balance, https://www.innerbalance.com/treatment/hrt" target="_blank" rel="noopener">Hormone replacement therapy page, including the provider's outcome, 503A, and “FDA announcement” language; checked August 10, 2026. ↩
17. 17. U.S. Food and Drug Administration, https://www.fda.gov/news-events/fda-direct-podcast/fda-direct-removing-black-box-warnings-hrt-part-12" target="_blank" rel="noopener">Menopause hormone therapy discussion hosted by FDA, November 2025, accessed August 10, 2026. ↩
18. 18. The Menopause Society, https://menopause.org/patient-education/menopause-topics/hormone-therapy" target="_blank" rel="noopener">Menopause Topics: Hormone Therapy, accessed August 10, 2026. ↩
19. 19. Inner Balance Help Center, https://help.innerbalance.com/en/articles/12760352-oestra-for-everyone" target="_blank" rel="noopener">Oestra formulas and strengths, checked August 10, 2026. ↩
20. 20. Inner Balance, https://www.innerbalance.com/p/learn/inner-balance-vs-alloy/" target="_blank" rel="noopener">Inner Balance vs Alloy comparison, checked August 10, 2026. ↩
21. 21. Inner Balance, https://www.innerbalance.com/p/learn/winona-review/" target="_blank" rel="noopener">Winona Review, publishing a four-times bioavailability claim and the 49% eight-week outcome set; checked August 10, 2026. ↩
22. 22. Inner Balance, https://www.innerbalance.com/p/learn/inner-balance-vs-alloy/" target="_blank" rel="noopener">Provider-owned comparison content identifying the founder's A4M certification, checked August 10, 2026. ↩
23. 23. American Board of Medical Specialties, https://www.abms.org/member-boards/" target="_blank" rel="noopener">Member Boards, accessed August 10, 2026. ↩
24. 24. American Academy of Anti-Aging Medicine, https://www.a4m.com/board-certification.html" target="_blank" rel="noopener">Board-certification program information, accessed August 10, 2026. ↩
25. 25. Inner Balance, provider-owned pages using 503B language, including https://www.innerbalance.com/p/learn/inner-balance-vs-alloy/" target="_blank" rel="noopener">Oestra comparison content, checked August 10, 2026. ↩
26. 26. Internal Revenue Service, https://www.irs.gov/publications/p502" target="_blank" rel="noopener">Publication 502: Medical and Dental Expenses, accessed August 10, 2026. FSA substantiation and card rules also depend on the user's plan documents. ↩
27. 27. The Menopause Society, https://menopause.org/patient-education/menopause-topics/hormone-therapy" target="_blank" rel="noopener">Menopause glossary and hormone-therapy guidance, accessed August 10, 2026. ↩
28. 28. British Menopause Society, https://thebms.org.uk/wp-content/uploads/2026/02/14-NEW-BMS-TfC-Progestogens-and-endometrial-protection-FEB2026-B.pdf" target="_blank" rel="noopener">Progestogens and endometrial protection, February 2026. ↩
29. 29. American College of Obstetricians and Gynecologists, https://pubmed.ncbi.nlm.nih.gov/41990335/" target="_blank" rel="noopener">Clinical Practice Update on the evaluation of postmenopausal bleeding, 2026. ↩
30. 30. U.S. Food and Drug Administration, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210132Orig1s000PharmR.pdf" target="_blank" rel="noopener">Bijuva NDA materials and https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214293Orig1s000ltr.pdf" target="_blank" rel="noopener">approval of generic estradiol/progesterone capsules. ↩
31. 31. National Academies of Sciences, Engineering, and Medicine, https://www.nationalacademies.org/read/25791/chapter/2" target="_blank" rel="noopener">The Clinical Utility of Compounded Bioidentical Hormone Therapy: Summary and Recommendations, 2020. ↩
32. 32. American College of Obstetricians and Gynecologists, https://pubmed.ncbi.nlm.nih.gov/37856860/" target="_blank" rel="noopener">Compounded Bioidentical Menopausal Hormone Therapy: Clinical Consensus No. 6, November 2023. ↩
33. 33. Inner Balance, https://www.innerbalance.com/about-us" target="_blank" rel="noopener">About Us and named care-team roster, counted and checked August 10, 2026. ↩